March 23, 2005
WASHINGTON--Pomegranate juice showed cardiovascular benefits in both laboratory mice and in cultured human coronary artery endothelial cells, according to a study published March 21, online ahead of print, in Proceedings of the National Academy of Sciences (www.pnas.org). The scientists reported antioxidant-rich pomegranate juice reduced progression of atherosclerosis by at least 30 percent in mice who were bred to have high cholesterol. Similarly, the cultured heart cells treated with the juice had a 50-percent increase in nitric oxide production, which helps blood vessels relax.
You May Also Like
Sep 28, 2023
Cognitive health growth comes out on top: A range of solutions for diverse needs continue to emerge and win – product development guideSep 25, 2023
LifeVantage proxy fight heats up as revenues coolSep 28, 2023
The ashwagandha root production process: Where tradition meets science – article part threeSep 21, 2023
Former FDA employees weigh in on gov’t shutdownSep 27, 2023